Pharmaceutical Secondary Packaging Market by Type of Secondary Packaging (Boxes, Cartons and Pouches), Type of Primary Packaging Packed (Ampoules, Blister Packs, Bottles, Cartridges, Syringes and Vials) and Key Geographies (North America, Europe, Asia-Pac

Pharmaceutical Secondary Packaging Market by Type of Secondary Packaging (Boxes, Cartons and Pouches), Type of Primary Packaging Packed (Ampoules, Blister Packs, Bottles, Cartridges, Syringes and Vials) and Key Geographies (North America, Europe, Asia-Pacific, MENA, Latin America, and RoW): Industry Trends and Global Forecasts, 2022-2035

INTRODUCTION

On an average, around 50 drugs are approved by the US Food and Drug Administration (US FDA) annually. Further, studies indicate that more than 100,000 tons of pharmaceutical products are consumed globally per year.In addition, over the next five years, the global pharmaceutical market is projected to grow at a CAGR of 4.7%, with global drug sales anticipated to raise revenues worth USD 1.5 trillion in 2023.This continuously growing pipeline of pharmaceutical drug products has inadvertently led to an increase in the demand for their associated primary and secondary packaging solutions. Specifically, pharmaceutical secondary packaging is a vital step in the product supply chain as it encloses life-saving drugs and therapies, preserving the identity, quality, integrity and stability of the packaged drug product.It also plays a key role in marketing and brand projection for a product. However, the process of secondary packaging usually involves time consuming and complex activities, such as blister carding, thermoforming, labeling, kitting, assembly and cold chain storage (for temperature sensitive biologics). Other key challenges faced by developers are limiting variability in packaging materials and ensuring compliance to stringent regulatory guidelines (for packaging designs).Considering the aforementioned concerns, many pharmaceutical players now prefer to collaborate with qualified packaging providers that offer non-traditional packaging solutions and have the required capabilities to create unique packaging designs, in a cost and time effective manner.

As per the CDMO Outsourcing Survey conducted by Nice Insight, specifically for clinical and commercial scale operations, nearly 60% of the pharmaceutical companies currently outsource their primary packaging needs, while 43% of the players outsource their secondary packaging requirements.At present, more than 160 companies offer secondary packaging solutions to the firms engaged in the pharmaceutical sector. Further, several recent advancements in packaging designs, technologies and materials have enabled service providers to offer a wide range of user-friendly pharmaceutical secondary packaging solutions. In addition, substantial expansions, mergers and acquisitions, and partnerships have been reported in this market as service providers strive to become one-stop-shops, in order to cater to the diverse needs of their clients engaged in the healthcare industry. Driven by the ongoing innovation in this field, continuous growth in the pharmaceutical drugs pipeline and a steady rise in drug approvals, the pharmaceutical secondary packaging market is likely to witness positive growth in the foreseen future.

SCOPE OF THE REPORT

The ‘Pharmaceutical Secondary Packaging Market – Distribution by Type of Secondary Packaging (Boxes, Cartons and Pouches), Type of Primary Packaging Packed (Ampoules, Blister Packs, Bottles, Cartridges, Syringes and Vials) and Key Geographies (North America, Europe, Asia-Pacific, MENA, Latin America, and Rest of the World): Industry Trends and Global Forecasts, 2022-2035’ report features an extensive study of the current market landscape and future potential of the pharmaceutical secondary packaging market. The study features an in-depth analysis, highlighting the capabilities of pharmaceutical secondary packaging providers. Amongst other elements, the report features:

A detailed overview of the overall landscape of companies offering secondary packaging solutions to the pharmaceutical and biotechnology industries, along with information on several relevant parameters, such as their year of establishment, company size (in terms of employee count), location of headquarters (North America, Europe, Asia-Pacific and rest of the world) and scale of operation (preclinical, clinical and commercial). The chapter also covers details related to the type of service provider (one-stop-shop service providers and stand-alone service providers), type of secondary packaging offered (cartons, boxes and others), type of primary packaging packed (blisters, vials, bottles, conventional syringes, ampoules, prefilled syringes and others), type of molecule packed (biologics, small molecules and unspecified), type of finished dosage form packed (solids, liquids / injectables, semi-solids, powders and others) and type of additional service(s) offered (labeling, serialization, kitting and cold-chain storage).

An insightful competitiveness analysis of the pharmaceutical secondary packaging providers, based on supplier power (in terms of years of experience), company competitiveness (type secondary packaging offered, type of primary packaging packed, type of molecule packed, type of finished dosage form packed, and type of additional services offered) and their respective scale of operation.

An analysis of recent partnerships inked between stakeholders engaged in this domain, during the period 2018-2021, covering acquisitions, manufacturing and packaging agreements, service alliances, packaging agreements, distribution agreements, technology utilization agreements and other related agreements. Further, the partnership activity in this domain has been analyzed based on various parameters, such as year of partnership, type of partnership, type of molecule packed, type of finished dosage form packed and most active players (in terms of number of partnerships). It also highlights the regional distribution of the partnership activity witnessed in this market.

A detailed analysis of the recent expansions undertaken by various pharmaceutical secondary packaging providers, based on several relevant parameters, such as year of expansion, type of expansion (capacity expansion, facility expansion and new facility), scale of operation, type of primary packaging packed, type of molecule packed, type of finished dosage form packed, company size, location of headquarters, location of expanded facility, most active players (in terms of number of recent expansions) and geographical distribution (region-wise and country-wise).

An in-depth analysis to estimate the current and future demand for pharmaceutical secondary packaging, based on several relevant parameters, such as type of secondary packaging (boxes, cartons and pouches), type of primary packaging packed (ampoules, blister packs, bottles, cartridges, syringes and vials) and key geographical regions (North America, Europe, Asia-Pacific, MENA, Latin America and rest of the world), for the period 2022-2035.

Elaborate profiles of prominent players (shortlisted based on a proprietary criterion) engaged in offering pharmaceutical secondary packaging solutions, across North America, Europe and Asia-Pacific. Each profile provides an overview of the company, featuring information on the year of establishment, number of employees, location of their headquarters, key executives, details related to its secondary packaging offerings, recent developments, and an informed future outlook.

One of the key objectives of the report was to evaluate the current opportunity and future potential associated with the pharmaceutical secondary packaging market, over the coming 13 years. We have provided an informed estimates of the likely evolution of the market in the short to mid-term and long term, for the period 2022-2035. Our year-wise projections of the current and future opportunity have further been segmented based on relevant parameters, such as [A] type of secondary packaging (boxes, cartons and others), [B] type of primary packaging packed (ampoules, blister packs, bottles, cartridges, syringes and vials) and [C] key geographical regions (North America, Europe, Asia-Pacific, MENA, Latin America and rest of the world). To account for future uncertainties in the market and to add robustness to our model, we have provided three forecast scenarios, portraying the conservative, base and optimistic tracks of the market’s evolution.

The opinions and insights presented in the report were also influenced by discussions held with senior stakeholders in the industry. The report features detailed transcripts of interviews held with the following individuals:
Jake Aspinall (Commercial Director, Active Pharma Supplies)
Silvio Del Deo (Managing Director, Depo Pack)
Joe Luke (Vice President, Sales and Marketing, Reed-Lane)

Market Segmentations

Pharmaceutical Secondary Packaging: Market Segmentations

Market Segments Details

Forecast Period 2022 - 2035

Type of Secondary Packaging Boxes

Cartons

Others

Type of Primary Packaging

Packed Ampoules

Blister Packs

Bottles

Cartridges

Syringes

Vials

key Geographical Regions

North America

Europe

Asia-Pacific

MENA

Latin America

Rest of the World

Source: Roots Analysis

RESEARCH METHODOLOGY

The data presented in this report has been gathered via secondary and primary research. For all our projects, we conduct interviews / surveys with experts in this domain (academia, industry, medical practice and other associations) to solicit their opinions on emerging trends in the market. This is primarily useful for us to draw out our own opinion on how the market will evolve across different regions and technology segments. Wherever possible, the available data has been checked for accuracy from multiple sources of information.

The secondary sources of information include

Annual reports

Investor presentations
SEC filings

Industry databases

News releases from company websites

Government policy documents

Industry analysts’ views

All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.

KEY QUESTIONS ANSWERED

Who are the leading players engaged in the pharmaceutical secondary packaging domain?

What is the relative competitiveness of different pharmaceutical secondary packaging providers?

Which type of partnership models are most commonly adopted by industry stakeholders?

What kind of expansion initiatives have been undertaken by pharmaceutical secondary packaging providers?

What is the present and likely future demand for secondary packaging solutions in the pharmaceutical sector?

How is the current and future market opportunity likely to be distributed across key market segments?

CHAPTER OUTLINES

Chapter 2 is an executive summary of the key insights captured during our research. It offers a high-level view on the likely evolution of the pharmaceutical secondary packaging market in the short to mid-term, and long term.

Chapter 3 provides a general overview of pharmaceutical packaging and importance / need for packaging in the pharmaceutical industry. Further, it contains a brief introduction to pharmaceutical secondary packaging, different types of pharmaceutical secondary packaging solutions and importance of secondary packaging in the pharmaceutical industry. The chapter concludes with a discussion on the key opportunity areas for secondary packaging providers and inputs on their projected growth in the coming years.

Chapter 4 features a detailed review of the current market landscape of around 165 companies offering pharmaceutical secondary packaging services. Additionally, it features an in-depth analysis of service providers, based on a number of relevant parameters, such as year of establishment, company size (in terms of employee count), location of headquarters and scale of operation (preclinical, clinical and commercial). Further, the chapter also covers details about type of service provider (one-stop-shop service providers and stand-alone service providers), type of secondary packaging offered (cartons, boxes and others), type of primary packaging packed (blisters, vials, bottles, conventional syringes, ampoules, prefilled syringes and others), type of molecule packed (biologics, small molecules and unspecified), type of finished dosage form packed (solids, liquids / injectables, semi-solids, powders and others) and type of additional services offered (labeling, serialization, kitting and cold-chain storage).

Chapter 5 presents an insightful competitiveness analysis of the pharmaceutical secondary packaging providers, located in North America, Europe, and Asia-Pacific and rest of the world. The companies are further segmented based on their employee count, into three categories, namely small (1-200 employees), mid-sized (201-500 employees) and large (>500 employees) across these geographies. The analysis compares the service providers on the basis of various parameters, such as supplier power (in terms of years of experience), company competitiveness (type secondary packaging offered, type of primary packaging packed, type of molecule packed, type of finished dosage form packed, and type of additional services offered) and scale of operation (preclinical, clinical and commercial).

Chapter 6 consist of detailed profiles of the prominent players (shortlisted based on a proprietary criterion) that are engaged in offering pharmaceutical secondary packaging in North America. Each profile provides an overview of the company, its pharmaceutical secondary packaging offerings and details on recent developments, as well as an informed future outlook.

Chapter 7 consist of detailed profiles of the prominent players (shortlisted based on a proprietary criterion) that are engaged in offering pharmaceutical secondary packaging in Europe. Each profile provides an overview of the company, its pharmaceutical secondary packaging offerings and details on recent developments, as well as an informed future outlook.

Chapter 8 consist of detailed profiles of the prominent players (shortlisted based on a proprietary criterion) that are engaged in offering pharmaceutical secondary packaging in Asia-Pacific. Each profile provides an overview of the company, its pharmaceutical secondary packaging offerings and details on recent developments, as well as an informed future outlook.

Chapter 9 features an insightful analysis of the various partnerships and collaborations that have been inked by stakeholders engaged in this domain (since 2018). It includes a brief description of the partnership models (including acquisitions, manufacturing and packaging agreements, service alliances, packaging agreements, distribution agreements, technology utilization agreements and others) adopted by stakeholders in the domain of pharmaceutical secondary packaging. Further, it comprises of analysis based on several relevant parameters such as year of agreement, type of agreement, type of molecule packed, type of finished dosage form packed and most active players (in terms of number of partnerships). Further, the chapter includes a world map representation of all the deals inked in this field in the period 2018-2021, highlighting both intercontinental and intracontinental partnership activity.

Chapter 10 presents a detailed analysis of the recent expansions undertaken (since 2018) by various pharmaceutical secondary packaging providers, based on several relevant parameters, such as year of expansion, type of expansion (capacity expansion, facility expansion and new facility), scale of operation (preclinical, clinical and commercial), type of primary packaging packed (blisters, bottles, syringes, vials, ampoules, sachets), type of molecule packed (biologics and small molecules), type of finished dosage form packed (solids and liquids), company size (in terms of employee count), location of headquarters (North America, Europe, Asia-Pacific and rest of the world), location of expanded facility, most active players (in terms of number of recent expansions) and geographical distribution (region-wise and country-wise).

Chapter 11 includes an in-depth analysis in order to estimate the current and future demand for pharmaceutical secondary packaging, based on several relevant parameters, such as type of secondary packaging (boxes, cartons and pouches), type of primary packaging packed (ampoules, blister packs, bottles, cartridges, syringes and vials) and key geographical regions (North America, Europe, Asia-Pacific, MENA, Latin America and rest of the world), for the period 2022-2035.

Chapter 12 presents an insightful market forecast analysis, highlighting the likely growth of the pharmaceutical secondary packaging market, for the period 2022-2035. Additionally, the report features the likely distribution of the current and forecasted opportunity across various relevant parameters such as [A] type of secondary packaging (boxes, cartons and others), [B] type of primary packaging packed (ampoules, blister packs, bottles, cartridges, syringes and vials) and [C] key geographical regions (North America, Europe, Asia-Pacific, MENA, Latin America and rest of the world).
Chapter 13 summarizes the overall report. In this chapter, we have provided a list of key takeaways from the report, and expressed our independent opinion related to the research and analysis described in the previous chapters.

Chapter 14 provides the transcripts of the interviews conducted with representatives from renowned organizations that are engaged in providing pharmaceutical secondary packaging. The chapter contains the details of our conversation with Jake Aspinall (Commercial Director, Active Pharma Supplies), Silvio Del Deo (Managing Director, Depo Pack) and Joe Luke (Vice President, Sales and Marketing, Reed-Lane).

Chapter 15 is an appendix, that provides tabulated data and numbers for all the figures included in the report.

Chapter 16 is an appendix that provides the list of companies and organizations that have been mentioned in the report.

LIST OF COMPANIES AND ORGANIZATIONS

The following companies and organizations have been mentioned in the report.

1. 3C! Packaging
2. 3R Pharmaceutical Industries
3. ABS (Australian Blister Sealing)
4. Acceleration Laboratory Services
5. Acorda Therapeutics
6. Active Pharma Supplies
7. Aenova
8. Alcami
9. Alcura
10. Alifarm Laboratories
11. allpack group
12. Almac Group
13. Alnylam Pharmaceuticals
14. Amcor
15. Amgen
16. Ansapack
17. Anthos Therapeutics
18. Aphena Pharma Solutions
19. Aquapak
20. AR Packaging
21. Ardena
22. Arkay Packaging
23. AstraZeneca
24. Atecna
25. Aucta Pharmaceuticals
26. Autajon
27. BAP Pharma
28. Bellwyck
29. Bellwyck Pharma Services (acquired by PCI Pharma Services)
30. Bemis
31. Berkshire Sterile Manufacturing
32. Berlin Packaging
33. Berry Global
34. Biotechnica (acquired by Central Pharma)
35. Birchwood Contract Manufacturing
36. Bormioli Pharma
37. Bristol-Myers Squibb
38. Bushu Pharma
39. Caligor Coghlan Pharma Services
40. Cannasupplies
41. Capsugel
42. Cardinal Health
43. Carton Service
44. Catalent
45. CCL Healthcare
46. CellBios
47. Central Pharma
48. CIT
49. CleanCut Technologies (acquired by Oliver Healthcare Packaging)
50. CMIC Group
51. Cobra Biologics
52. Constantia Flexibles
53. Content Group
54. CordenPharma
55. CoreRx
56. Corplex
57. Coveris
58. CREAPHARM
59. CRNA Pharma
60. CRYOPDP
61. Cryoport Systems
62. CWS Contract Packaging
63. Dec Group
64. Depo Pack
65. Dr. Müller Pharma
66. DS Smith
67. Dunamis Packaging
68. East Pharma Technologies
69. Ecobliss
70. elpack
71. Endeavour Foundation
72. Essentra Packaging
73. Eumedica
74. Eurofins CDMO
75. EVERSANA
76. Experic
77. Faller Packaging
78. Falorni Pharma
79. Fermion (subsidiary of Orion)
80. FIDELIO Healthcare
81. First Wave BioPharma
82. Firstan Holdings (acquired by AR Packaging)
83. G&W Laboratories
84. GCL Pharma
85. GHO Capital
86. Global Pharma CM
87. good natured
88. Graphic Packaging International
89. HENNIG ARZNEIMITTEL
90. HERMES PHARMA
91. Honeywood (acquired by Wasdell Group)
92. Howell Packaging
93. Hughes Enterprises
94. Huhtamaki
95. IMP Pharmaceutical Services
96. Inno4Life (acquired by Dec Group)
97. Innova Medical Group
98. Intrapak
99. IRISYS (acquired by Recro)
100. Janssen
101. Jones Healthcare Group
102. K+D (acquired by AR Packaging)
103. Kansas City Design (acquired by Oliver Healthcare Packaging)
104. KapStone (acquired by WestRock)
105. Kerry Pharma
106. Keystone Folding Box
107. KFM Co-Packer
108. KISHORE GROUP
109. Klocke Group
110. Klocke of America
111. Konsyl Pharmaceuticals
112. Körber Pharma
113. Koru Pacific Packaging
114. Kroha (acquired by AR packaging)
115. Kymanox
116. Leca Graphics
117. Legacy Pharma Solutions
118. Linkx Packaging Systems (acquired by WestRock)
119. Lonza
120. LSNE Contract Manufacturing
121. Lutz Packaging
122. Mak Pharma
123. Manufacture Générale de Joints (MGJ)
124. McKesson RxPak
125. MED PACK
126. Med-X-Press
127. Mikart (acquired by Nautic Partners)
128. Mission Pharmacal
129. MM Packaging
130. Moderna
131. Mondi Group
132. Morgen Pharmaceutical Services (MPhS)
133. Nautic Partners
134. Nedupack Thermoforming
135. Network Partners
136. NUVISAN
137. Oliver Healthcare Packaging
138. Omaks Printing and Packaging
139. oncomed
140. Origin Pharma Packaging
141. Orlando-Equity
142. Orofino Pharmaceuticals
143. PACS International
144. Palladio Group
145. Pangraph
146. PaperFoam
147. Paperpack
148. Paras Printpack
149. Parle Global Technologies
150. Patheon (Thermo Fischer Scientific)
151. PCI Pharma Services
152. Pelican BioThermal
153. Pemcor Packaging
154. Performance Systematix (acquired by Selig Group)
155. Pfizer CentreOne
156. Pharma Packaging Solutions (acquired by Tjoapack)
157. Pharma Print (acquired by Faller Packaging)
158. Pharmaceutical Contractors
159. Pharmaceutical Packaging Professionals (acquired by PCI Pharma Services)
160. Pharmaserv Logistics
161. Pharmasol
162. Pharmeco
163. Phathom Pharmaceuticals
164. Photocure
165. Piramal Pharma Solutions
166. PKG Packaging
167. Planned Packaging Films (acquired by Wasdell Group)
168. Plymouth Packaging (acquired by WestRock)
169. Praxis Packaging Solutions
170. Prespack
171. Prince Art Packages
172. Qualiskills
173. Quality Chemicals
174. Quality Packaging Specialists International (QPSI)
175. Quinta-Analytica
176. Recipharm
177. Recro
178. Reed-Lane
179. RENOLIT Healthcare
180. REPASSA
181. rlc Packaging Group (acquired by AR Packaging)
182. Rondo-Pak
183. Ropack Pharma Solutions
184. Salus Group
185. SANTA Pharm
186. Santen Pharmaceutical
187. Schluter Print Pharma Packaging (acquired by WestRock)
188. SCHOTT
189. Selig Flexibles
190. Sentry BioPharma Services
191. Sepha
192. Seveillar Clinical Supplies
193. SGD Pharma
194. Sharp
195. Sherpa Clinical Packaging (acquired by PCI Pharma Services)
196. Singota Solutions
197. SkyePharma
198. Smurfit Kappa
199. Sonoco
200. Spectrum Pharma
201. SteriPack
202. Stevanato Group
203. Supply Chain Wizard
204. Suzuken
205. Swiftpak
206. SYNERLAB Group
207. Syntegon
208. Takeda Pharmaceutical
209. Tapemark
210. Tenco Assemblies
211. Teva-Takeda Pharmaceuticals
212. The FlexPro Group
213. Therabel
214. Tjoapack
215. Total Health Centre
216. TriRx Pharmaceutical Services
217. TT-print (acquired by Constantia Flexibles)
218. Unette
219. Unither Pharmaceuticals
220. Veratrak
221. Verpak Ambalaj
222. Vetter Pharma
223. Vihaa Print And Pack
224. Voigt Industrie Service
225. Wasdell Group
226. West Pharmaceutical Services
227. WestRock
228. Wuxi Griffin
229. Xellia Pharmaceuticals
230. Xerimis
231. Yourway



Please note that the publisher limits purchases by consulting clients to either Consulting Company Team License or Global Site License for Entire Company. Any other selections will not be fulfilled by this publisher.